Technical Analysis for ORIC - Oric Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
C 14.68 -2.78% -0.42
ORIC closed down 2.78 percent on Monday, March 18, 2024, on 1.29 times normal volume.
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
Wide Bands Range Expansion 0.00%
Boomer Buy Setup Bullish Swing Setup -2.78%
Pocket Pivot Bullish Swing Setup -2.78%
Volume Surge Other -2.78%
NR7 Range Contraction -2.78%
Earnings Movers Other -2.78%
Inside Day Range Contraction -2.78%
Wide Bands Range Expansion -2.78%
Earnings Movers Other -2.26%

   Recent Intraday Alerts

Alert Time
Down 5% about 17 hours ago
10 DMA Resistance about 17 hours ago
Down 3% about 17 hours ago
Fell Below Previous Day's Low about 17 hours ago
Down 2 % about 17 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers. Its lead product candidate is ORIC-101, a small molecule antagonist of the glucocorticoid receptor, which has been linked to resistance to multiple classes of cancer therapeutics across various solid tumors. The company's second product candidate is ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens. It is also developing multiple precision medicines targeting other cancer resistance mechanisms. The company was founded in 2014 and is headquartered in South San Francisco, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Clinical Medicine Solid Tumors Immunotherapy Treatment Of Cancer Cancer Treatment Oncology Chemotherapy Antineoplastic Drugs Occupational Safety And Health Precision Medicine Specialty Drugs Cancer Therapeutics Cd73

Is ORIC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 16.63
52 Week Low 4.6
Average Volume 587,660
200-Day Moving Average 8.60
50-Day Moving Average 11.72
20-Day Moving Average 13.59
10-Day Moving Average 15.18
Average True Range 0.99
RSI (14) 59.84
ADX 34.07
+DI 28.00
-DI 19.02
Chandelier Exit (Long, 3 ATRs) 13.66
Chandelier Exit (Short, 3 ATRs) 12.93
Upper Bollinger Bands 17.56
Lower Bollinger Band 9.61
Percent B (%b) 0.64
BandWidth 58.52
MACD Line 1.04
MACD Signal Line 1.07
MACD Histogram -0.0311
Fundamentals Value
Market Cap 984.32 Million
Num Shares 67.1 Million
EPS -1.98
Price-to-Earnings (P/E) Ratio -7.41
Price-to-Sales 0.00
Price-to-Book 3.43
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.18
Resistance 3 (R3) 16.19 15.69 15.93
Resistance 2 (R2) 15.69 15.31 15.69 15.85
Resistance 1 (R1) 15.19 15.08 14.94 15.18 15.76
Pivot Point 14.69 14.69 14.57 14.69 14.69
Support 1 (S1) 14.19 14.31 13.94 14.18 13.60
Support 2 (S2) 13.69 14.08 13.69 13.51
Support 3 (S3) 13.19 13.69 13.43
Support 4 (S4) 13.18